EI
Eikon Therapeutics, Inc. Common Stock (EIKN)
NASDAQ·Healthcare·Biotechnology
$5.79
-1.53%
Mkt Cap $287.48M
Analyst Ratings
Buy
0
Hold
0
Sell
1
Price Target (2 analysts)
$14.00
Range $5.00 – $23.00
Implied Upside
+142.0%
Consensus $14.00 vs current $5.79